Paul B Manning

Director, Liquidia Corp; Director, Candel Therapeutics, Inc.; Director, 10% owner, Verrica Pharmaceuticals Inc.

Bought, 12 months

$20.5M

Sold, 12 months

$12.8M

Companies

Latest trade

Jun 4, 2026

Companies

Liquidia CorpDirector −$12.8M Candel Therapeutics, Inc.Director +$3.0M Verrica Pharmaceuticals Inc.Director, 10% owner +$17.5M

Trades

LQDA Sold 200,000 shares at $63.91 $12.8M Jun 4

CADL Bought 550,458 shares at $5.45 $3.0M Feb 23

VRCA Bought 4,126,142 shares at $4.24 $17.5M Nov 25

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.